Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: A systematic review and network meta analysis

Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: A systematic review and network meta analysis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of haemostatic drugs (including antifibrinolytics) and topical agents for reducing bleeding, transfusion, and reoperation in adults undergoing cardiac surgery.

Bibliografski detalji
Glavni autori:	Beverly, A, Ong, G, Wilkinson, K, Doree, C, Welton, N, Estcourt, L
Format:	Journal article
Jezik:	English
Izdano:	Cochrane Collaboration 2019

Slični predmeti

Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis
od: Beverly, A, i dr.
Izdano: (2023)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures
od: Huber, J, i dr.
Izdano: (2019)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
od: Huber, J, i dr.
Izdano: (2017)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non‐cardiac surgery or invasive procedures
od: Huber, J, i dr.
Izdano: (2018)

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
od: Gibbs, VN, i dr.
Izdano: (2024)

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a Cochrane systematic review and network meta-analysis
od: Gibbs, V, i dr.
Izdano: (2024)

Red cell transfusions for prevention of bleeding: a systematic review and meta-analysis of randomized controlled trials
od: Desborough, M, i dr.
Izdano: (2016)

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
od: Estcourt, L, i dr.
Izdano: (2019)

Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews
od: Lewis, SR, i dr.
Izdano: (2023)

The difference in potential harms between whole blood and component blood transfusion in major bleeding: A rapid systematic review and meta-analysis of RCTs
od: Geneen, LJ, i dr.
Izdano: (2021)

The Effect of Aspirin on Bleeding and Transfusion in Contemporary Cardiac Surgery.
od: Jordan E Goldhammer, i dr.
Izdano: (2015-01-01)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
od: Estcourt, L, i dr.
Izdano: (2012)

The Effect of Cell Salvage on Bleeding and Transfusion Needs in Cardiac Surgery
od: Frixos Tachias, i dr.
Izdano: (2022-01-01)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
od: Butler, C, i dr.
Izdano: (2011)

Predictive Factors of Medical Bleeding in Adult Patients Undergoing Cardiac Surgery
od: Alejandro Dussich, i dr.
Izdano: (2005-06-01)

Pathogen-reduced platelets for the prevention of bleeding.
od: Butler, C, i dr.
Izdano: (2013)

Pathogen-reduced platelets for the prevention of bleeding (Review)
od: Estcourt, L, i dr.
Izdano: (2017)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
od: Estcourt, L, i dr.
Izdano: (2014)

Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease
od: Wilkinson, K, i dr.
Izdano: (2014)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review
od: Desborough, M, i dr.
Izdano: (2016)

Pathogen-reduced platelets for the prevention of bleeding (Review)
od: Butler, C, i dr.
Izdano: (2013)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Estcourt, L, i dr.
Izdano: (2015)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
od: Estcourt, L, i dr.
Izdano: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
od: Estcourt, L, i dr.
Izdano: (2018)

Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation of hip, pelvic and long bone fractures: A systematic review and network meta‐analysis
od: Gibbs, V, i dr.
Izdano: (2019)

Network meta-analysis results: pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis
od: Sandercock, J, i dr.
Izdano: (2023)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review
od: Desborough, M, i dr.
Izdano: (2016)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
od: Desborough, M, i dr.
Izdano: (2016)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
od: Estcourt, L, i dr.
Izdano: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, i dr.
Izdano: (2014)

Six‐month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial)
od: Estcourt, L, i dr.
Izdano: (2019)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Crighton, GL, i dr.
Izdano: (2015)

Intravenous Tranexamic Acid Reduces Post-Operative Bleeding and Blood Transfusion in Patients Undergoing Aortic Surgery: A PRISMA-Compliant Systematic Review and Meta-Analysis
od: Bo Zhang, i dr.
Izdano: (2023-04-01)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, i dr.
Izdano: (2014)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
od: Estcourt, L, i dr.
Izdano: (2015)

Definitions of massive transfusion in adults with critical bleeding: a systematic review
od: Victor S. Lin, i dr.
Izdano: (2023-07-01)

Electrolyte changes induced by massive transfusion in patients undergoing cardiac surgery
od: Xusheng CHEN, i dr.
Izdano: (2022-06-01)

Desmopressin to reduce periprocedural bleeding and transfusion: a systematic review and meta-analysis
od: Carol Wang, i dr.
Izdano: (2024-01-01)

Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials
od: Stokes Barrie J, i dr.
Izdano: (2005-07-01)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian translation of Cochrane plain language summary)
od: Desborough, MJR, i dr.
Izdano: (2021)